U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
192691192691Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: gefitinibhttps://ClinicalTrials.gov/show/NCT00024089
192692192692Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerCompletedNo Results AvailableLung Cancer|Malignant Mesothelioma|Metastatic Cancer|Thymoma and Thymic CarcinomaProcedure: radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT00024076
192693192693SU006668 in Treating Patients With Advanced Solid TumorsActive, not recruitingNo Results AvailableBreast Cancer|Colorectal Cancer|Gastric Cancer|Kidney Cancer|Lung Cancer|Multiple Myeloma and Plasma Cell Neoplasm|Pancreatic Cancer|Prostate CancerDrug: orantinibhttps://ClinicalTrials.gov/show/NCT00024063
192694192694Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Drug: methotrexate|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00024050
192695192695Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow TransplantationCompletedNo Results AvailableOral ComplicationsProcedure: management of therapy complicationshttps://ClinicalTrials.gov/show/NCT00024037
192696192696BMS-275291 in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNo Results AvailableSarcomaDrug: rebimastathttps://ClinicalTrials.gov/show/NCT00024024
192697192697PS-341 in Treating Patients With Metastatic Malignant MelanomaCompletedNo Results AvailableRecurrent Melanoma|Stage IV MelanomaDrug: bortezomib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00024011
192698192698Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic OsteosarcomaCompletedNo Results AvailableMetastatic OsteosarcomaDrug: doxorubicin hydrochloride|Drug: cisplatin|Drug: methotrexate|Drug: leucovorin calcium|Biological: filgrastim|Procedure: therapeutic conventional surgery|Radiation: radiation therapy|Drug: etoposide|Drug: ifosfamide|Biological: trastuzumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00023998
192699192699Vaccine Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerBiological: autologous tumor cell vaccine|Biological: therapeutic autologous dendritic cells|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00023985
192700192700Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: exatecan mesylate|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00023972
192701192701Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNo Results AvailableMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent IDrug: hydroxyurea|Drug: fluorouracil|Biological: bevacizumab|Radiation: radiation therapy|Biological: filgrastim|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00023959
192702192702BMS-247550 in Treating Patients With Liver or Gallbladder CancerTerminatedNo Results AvailableAdult Primary Cholangiocellular Carcinoma|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Localized Extrahepatic Bile Duct Cancer|Localized GDrug: ixabepilone|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00023946
192703192703Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal CancerCompletedNo Results AvailableAdenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal CancerDrug: iodine I 131 monoclonal antibody CC49-deltaCH2https://ClinicalTrials.gov/show/NCT00023933
192704192704Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous LeukemiaTerminatedNo Results AvailableBlastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBiological: bevacizumab|Drug: idarubicin|Drug: cytarabinehttps://ClinicalTrials.gov/show/NCT00023920
192705192705Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00023907
192706192706Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: alvocidibhttps://ClinicalTrials.gov/show/NCT00023894
192707192707Bortezomib in Treating Patients With Chronic Myelogenous LeukemiaCompletedNo Results AvailableLeukemiaDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00023881
192708192708Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNo Results AvailableColorectal Cancer|Metastatic CancerDrug: FOLFIRI regimen|Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: mitomycin Chttps://ClinicalTrials.gov/show/NCT00023868
192709192709PS-341 and Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: bortezomib|Drug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00023855
192710192710BCG With or Without Mitomycin in Treating Patients With Bladder CancerCompletedNo Results AvailableBladder CancerBiological: BCG vaccine|Drug: mitomycin C|Procedure: adjuvant therapy|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00023842
192711192711Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNo Results AvailableProstate CancerDrug: bicalutamide|Drug: flutamide|Drug: releasing hormone agonist therapy|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00023829
192712192712Carbendazim in Treating Patients With Advanced Solid Tumors or LymphomaActive, not recruitingNo Results AvailableLymphoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: carbendazimhttps://ClinicalTrials.gov/show/NCT00023816
192713192713Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinTerminatedNo Results AvailableBreast Cancer|Head and Neck Cancer|Lymphoma|Metastatic Cancer|Non-melanomatous Skin Cancer|SarcomaDrug: silicon phthalocyanine 4https://ClinicalTrials.gov/show/NCT00023790
192714192714S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: filgrastim|Biological: sargramostim|Drug: cytarabine|Drug: daunorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00023777
192715192715Bortezomib in Treating Patients With Lymphoproliferative DisordersCompletedHas ResultsRecurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell LymphomaDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00023764
192716192716Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal CancerCompletedNo Results AvailableColorectal CancerDrug: fluorouracil|Drug: leucovorin calcium|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00023751
192717192717Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue SarcomaCompletedNo Results AvailableSarcomaBiological: filgrastim|Drug: dacarbazine|Drug: doxorubicin hydrochloride|Drug: ifosfamide|Drug: semaxanib|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00023738
192718192718Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue SarcomaCompletedNo Results AvailableSarcomaDrug: semaxanib|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00023725
192719192719Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedHas ResultsPrimary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial CancerDrug: bortezomib|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00023712
192720192720Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: gefitinibhttps://ClinicalTrials.gov/show/NCT00023699

* Görseller ve İçerik tekif hakkına sahip olabilir